Skip to main content
19 April 2024
Last updated:
Thursday 18 April 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
European biotechs match gains in US market
Read more
Value-based drug pricing coming soon in UK
Read more
Diabetes reimbursement at risk in Germany
Read more
2012 was the year of the antibody developer
Read more
Adaptive licensing: A new approach for drug approvals
Read more
EU Transparency Directive: changes afoot on pricing and reimbursement
Read more
Encode project produces many findings
Read more
German drug policy puts pressure on prices in Europe
Read more
Advances in DNA sequencing drive medical discovery
Read more
Avastin vs Lucentis: the drug reimbursement dilemma of the century
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
14
Page
15
Page
16
Page
17
Page
18
Page
19
Current page
20
Page
21
Page
22
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form